fda ban on compounded semaglutide ๐จ Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA is moving to restrict
Description
As rates for obesity and cardiovascular disease increase, so too does the demand for GLP-1 drugs.
Concern about GLP therapy, bone density, and fracture risk

GLP-1 weight loss drugs will be a lot cheaper for many older Americans with the rollout of Medicares $50-a-month GLP-1 program.

Learn how starting doses differ and why clinicians dont compare them directly.

Hertzel Gerstein cautions Canadians that semaglutide is a powerful drug, not a supplement, as the second generic clears Health Canada.

Discover how GLP-1 injections like Wegovy and Mounjaro help with weight loss management
